Compare JetBlue Airways Corporation (JBLU) vs Vaxcyte Inc. Common Stock (PCVX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
JetBlue Airways Corporation vs Vaxcyte Inc. Common Stock — how do they compare? JetBlue Airways Corporation trades at $3.1 (market cap $1.13B), while Vaxcyte Inc. Common Stock trades at $67.1 (market cap $10.63B). The key difference: Vaxcyte Inc. Common Stock is far larger — about 9.4× JetBlue Airways Corporation's market cap, and Vaxcyte Inc. Common Stock is trading nearer its 52-week high, JetBlue Airways Corporation nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold JetBlue Airways Corporation for 44 Days and Vaxcyte Inc. Common Stock for 0 Days on average.
| JBLU | PCVX | |
|---|---|---|
Market Cap | $1.13B | $10.63B |
Volume | 40,474,891 | 1,525,205 |
Sector | Industrials | Health |
52-Week High | $6.46 | $73.82 |
52-Week Low | $3.01 | $40.32 |
Typical Hold Time | 44 Days | 0 Days |
Enterprise Value | $8.50B | $9.26B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
JetBlue Airways (JBLU) trades at $3.35, down 7.46% in the last session, reflecting ongoing challenges in the airline sector. The stock shows bearish technical signals with mixed fundamentals - while valuation ratios like P/S (0.12) and P/B (0.71) appear attractive, the company continues to report negative earnings with a -9.32% net income margin. Recent developments include route expansion to Colombia and the launch of BlueFirst premium seating, though fuel cost pressures and capacity adjustments remain headwinds.
The investment outlook remains cautious given persistent losses and high debt levels (51.28% debt-to-asset ratio). While analyst consensus suggests 62% upside to the $5.89 price target, execution risks and industry volatility warrant careful consideration. The key opportunity lies in operational turnaround potential, but investors face significant exposure to fuel prices and competitive pressures in the crowded airline market.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About JetBlue Airways Corporation
JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It carries over millions of customers with an average of more than 1,000 daily flights and served approximately 99 destinations in the United States, the Caribbean, and Latin America. The company currently operates Airbus A321, Airbus A320, and Embraer E190 aircraft types.
Read more on JBLU →About Vaxcyte Inc. Common Stock
Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →
